VEGF News and Research

RSS
VEGF is a substance made by cells that stimulates new blood vessel formation. Also called vascular endothelial growth factor.
Scientists identify molecule that could be targeted to prevent vision loss in diabetics and preterm infants

Scientists identify molecule that could be targeted to prevent vision loss in diabetics and preterm infants

Study finds useful way to evaluate impact of stress in AMD

Study finds useful way to evaluate impact of stress in AMD

Scientists engineer smallest CRISPR-Cas9 system to date

Scientists engineer smallest CRISPR-Cas9 system to date

New biomarker helps better predict survival after surgical removal of colorectal metastases

New biomarker helps better predict survival after surgical removal of colorectal metastases

New techniques and treatments show promise for eliminating retinopathy of prematurity

New techniques and treatments show promise for eliminating retinopathy of prematurity

KIT researchers prove that neurons regulate blood vessel growth

KIT researchers prove that neurons regulate blood vessel growth

Powerful version of anti-inflammatory molecule may help protect vision in diabetic retinopathy

Powerful version of anti-inflammatory molecule may help protect vision in diabetic retinopathy

TSRI scientists reveal how vision-loss treatment may leave the eyes, kidneys vulnerable to cellular damage

TSRI scientists reveal how vision-loss treatment may leave the eyes, kidneys vulnerable to cellular damage

Combination of demineralized bone and gene therapy shows promise for treating pseudarthrosis

Combination of demineralized bone and gene therapy shows promise for treating pseudarthrosis

Combination treatment may be valuable therapeutic option for HER2-negative metastatic breast cancer

Combination treatment may be valuable therapeutic option for HER2-negative metastatic breast cancer

IQWiG finds colorectal cancer drug combination has added benefit only for some patients

IQWiG finds colorectal cancer drug combination has added benefit only for some patients

New review highlights challenges of studying resistance to antiangiogenic treatment in preclinical models

New review highlights challenges of studying resistance to antiangiogenic treatment in preclinical models

Researchers identify pathway that helps cancer cells to aggressively spread in the brain

Researchers identify pathway that helps cancer cells to aggressively spread in the brain

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Experimental drug outperforms standard first-line therapy for advanced kidney cancer patients

Experimental drug outperforms standard first-line therapy for advanced kidney cancer patients

High-altitude dwellers prone to chronic mountain sickness produce huge amounts of red blood cells

High-altitude dwellers prone to chronic mountain sickness produce huge amounts of red blood cells

Heart problems from common cancer treatment can be alleviated by using gene therapy

Heart problems from common cancer treatment can be alleviated by using gene therapy

Discovery of neuropilin 2 deficiency may lead to new therapies for edema and lymphedema

Discovery of neuropilin 2 deficiency may lead to new therapies for edema and lymphedema

ATS releases new clinical practice guidelines for diagnosis, management of LAM

ATS releases new clinical practice guidelines for diagnosis, management of LAM

HIF-2 inhibitors could be promising target to combat kidney cancer

HIF-2 inhibitors could be promising target to combat kidney cancer